by Five Rivers Rx | Oct 22, 2020 | Industry News, Uncategorized
The Maryland Board of Pharmacy became the 4th state to accept NCDQS QAS Accreditation or Inspection program as part of their licensing requirement as of their October 21, 2020 meeting. Maryland The Maryland Board of Pharmacy has required out-of-state applicants to...
by Five Rivers Rx | Sep 23, 2020 | Industry News
The pharmaceutical supply chain industry is now funding New York’s efforts to combat the opioid crisis through two separate mechanisms. Originally New York state legislature passed the Opioid Stewardship Act (OSA) that was designed to collect $100 million per year for...
by Five Rivers Rx | Aug 27, 2020 | Industry News
New headwinds are developing against the independent pharmacy, a business model that is already in a bitter fight against PBMs and payors in the space. New Entrants in Prescription Delivery Likely the splashiest news, Uber Health announced last week that they...
by Five Rivers Rx | Aug 12, 2020 | Industry News, Regulations
The DSCSA has had wide-ranging implications on state regulation of the pharmaceutical supply chain. But are some states using it as an opportunity to increase their oversight which has resulted in onerous requirements for the industry? Background In early 2019,...
by Five Rivers Rx | Jul 30, 2020 | Industry News, Regulations
The patchwork that is state licensure is a constant challenge for all companies in the pharmaceutical supply chain – from international drug manufacturers to independent distributors. Companies not in compliance are at significant risk of being caught by state...
by Five Rivers Rx | May 20, 2020 | DEA, Industry News, Suspicious Order Monitoring
Omnicare, a leading provider of closed-door pharmacy services, agreed to pay more than a $15 million civil penalty for allowing opioids and other controlled substances to be dispensed without a valid prescription. The fine zeroes in on a common issue amongst...
